Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gabriel Taricani Kubota"'
Autor:
Gabriel Taricani Kubota
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 80, Iss 5 suppl 1, Pp 218-226 (2022)
ABSTRACT The result of more than thirty years of research, anti-CGRP monoclonal antibodies are currently the state of the art for migraine preventive therapy. Their efficacy and safety, supported by an already large and growing body of evidence, are
Externí odkaz:
https://doaj.org/article/9b47c06a540b437cbd2ebaf8e78b9fb9
Autor:
Adalberto STUDART-NETO, Bruno Fukelmann GUEDES, Raphael de Luca e TUMA, Antonio Edvan CAMELO FILHO, Gabriel Taricani KUBOTA, Bruno Diógenes IEPSEN, Gabriela Pantaleão MOREIRA, Júlia Chartouni RODRIGUES, Maíra Medeiros Honorato FERRARI, Rafael Bernhart CARRA, Raphael Ribeiro SPERA, Mariana Hiromi Manoel OKU, Sara TERRIM, Cesar Castello Branco LOPES, Carlos Eduardo Borges PASSOS NETO, Matheus Dalben FIORENTINO, Julia Carvalhinho Carlos DE SOUZA, José Pedro Soares BAIMA, Tomás Fraga Ferreira DA SILVA, Cristiane Araujo Martins MORENO, Andre Macedo Serafim SILVA, Carlos Otto HEISE, Rodrigo Holanda MENDONÇA, Ida FORTINI, Jerusa SMID, Tarso ADONI, Marcia Rubia Rodrigues GONÇALVES, Samira Luisa Apóstolos PEREIRA, Lecio Figueira PINTO, Helio Rodrigues GOMES, Edmar ZANOTELI, Sonia Maria Dozzi BRUCKI, Adriana Bastos CONFORTO, Luiz Henrique Martins CASTRO, Ricardo NITRINI
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 78, Iss 8, Pp 494-500 (2020)
ABSTRACT Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with
Externí odkaz:
https://doaj.org/article/da20a0697c924fa5afc1679e11a7fef6
Autor:
Ana Beatriz Ayroza Galvão Ribeiro Gomes, Mauro Henrique, Jr, Vinicius Andreoli Schoeps, Mariana Monteiro Saldanha Altenfelder Santos, Ada Pellegrinelli, Bárbara Pessoa de Matos, Gabriel Taricani Kubota, Haniel Alves Araújo, Letícia Sant' Ana Cardoso da Silva, Fabrício de Paula Leite Battisti, Bruno Yukio Kubota, Areta Cavalcanti Ferreira, Mateus Paquesse Pellegrino, Renata de Andrade Prado, Ronaldo Abrahm, Vivian Dias Baptista Gagliardi, Marcel Simis, Rubens José Gagliardi
Publikováno v:
eNeurologicalSci, Vol 6, Iss C, Pp 63-67 (2017)
Context and objective: Cerebrovascular disease is one of the most important causes of death and disability worldwide. The patient's inability to identify the warning signs of stroke substantially delays the search for emergency services, which is rel
Externí odkaz:
https://doaj.org/article/a38be8fc46874414a417e3c7ed7b20cd
Autor:
Breno José Alencar Pires Barbosa, Marcelo Houat de Brito, Júlia Chartouni Rodrigues, Gabriel Taricani Kubota, Jacy Bezerra Parmera
Publikováno v:
Dementia & Neuropsychologia, Vol 11, Iss 4, Pp 459-461
ABSTRACT. A 75-year-old right-handed woman presented to the emergency department with simultanagnosia and right unilateral optic ataxia. Moreover, the patient had agraphia, acalculia, digital agnosia and right-left disorientation, consistent with com
Externí odkaz:
https://doaj.org/article/3944a3b9ed4944bca152ce264e9b8891
Autor:
Daniel Ciampi de Andrade, Jefferson Rosi, Raissa Tibes, Liu Dongyang, Ana Mércia Fernandes, Gabriel Taricani Kubota, Valquíria Aparecida da Silva, Camila Squarzoni Dale, Ricardo Galhardoni, Pedro Henrique Martins da Cunha, João Sato, Clarice Listik, Manoel Jacobsen Teixeira
Publikováno v:
Neurophysiologie Clinique. 51:291-302
Objectives Peripheral neuropathic pain (pNeP) is prevalent, and current treatments, including drugs and motor cortex repetitive transcranial magnetic stimulation (rTMS) leave a substantial proportion of patients with suboptimal pain relief. Methods W
Publikováno v:
Revista Paulista de Reumatologia. :17-27
A dor neuropática é uma condição clinicamente definida e provocada por uma lesão ou doença de vias neurológicas somatossensitivas. Ela ocorre em aproximadamente 7% a 10% da população mundial, e resulta em grande impacto econômico e sobre a
Autor:
Ricardo Nitrini, Jerusa Smid, Matheus Dalben Fiorentino, Maíra Medeiros Honorato Ferrari, Tarso Adoni, Mariana Hiromi Manoel Oku, Luiz Henrique Martins Castro, Carlos Otto Heise, Gabriela Pantaleão Moreira, Sonia Maria Dozzi Brucki, Márcia Rúbia Rodrigues Gonçalves, Raphael Ribeiro Spera, Rodrigo de Holanda Mendonça, Adalberto Studart-Neto, Júlia Chartouni Rodrigues, Rafael Bernhart Carra, André Macedo Serafim da Silva, Tomás Fraga Ferreira Da Silva, Cesar Castello Branco Lopes, Raphael de Luca e Tuma, Bruno Diógenes Iepsen, Edmar Zanoteli, Antonio Edvan Camelo Filho, Cristiane de Araújo Martins Moreno, Sara Terrim, Carlos Eduardo Borges Passos Neto, Julia Carvalhinho Carlos De Souza, Bruno Fukelmann Guedes, Lécio Figueira Pinto, José Pedro Soares Baima, Ida Fortini, Samira Luisa dos Apostolos Pereira, Gabriel Taricani Kubota, Adriana Bastos Conforto, Hélio Rodrigues Gomes
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 78, Iss 8, Pp 494-500 (2020)
Arquivos de Neuro-Psiquiatria v.78 n.8 2020
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria v.78 n.8 2020
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse out
Autor:
Manoel Jacobsen Teixeira, Daniel Ciampi de Andrade, Irina Raicher, Arthur José Maia Lopes, Ricardo Galhardoni, Valquíria Aparecida da Silva, Catarina Lins, Luciana Mendes Bahia Menezes, Gabriel Taricani Kubota, Kleber Paiva Duarte
Publikováno v:
Brazilian Neurosurgery, Vol 39, Iss 03, Pp 228-231 (2020)
Colorectal cancer is one of the most common oncological diseases. Chemotherapy is usually recommended as an adjuvant treatment for stage-II, -III, and -IV tumors. Approximately 10% of the patients develop neuropathic pain after chemotherapy, and they
Publikováno v:
European Journal of Pain (London, England)
Background Pain has been frequently described as a clinical feature of COVID‐19, and the main pain syndromes that have been associated with the acute phase of this disease so far are headache, myalgia, arthralgia, and neuropathic pain. Understandin
Autor:
Adriano Donizeth Silva de Morais, Felipe Henriques Carvalho Soares, Vitor Hugo Honorato Pereira, Pedro Henrique Martins da Cunha, Ana Mércia Fernandes, Jorge Dornellys da Silva Lapa, Daniel Ciampi de Andrade, Matheus Merula de Almeida, Catarina Couras, Luíza Mansur Braga, Bruno Hojo, Bárbara Costa, Gabriel Taricani Kubota, Manoel Jacobsen Teixeira
Publikováno v:
European Journal of Pain (London, England)
BACKGROUND: We assessed whether COVID-19 is associated with de novo pain and de novo chronic pain (CP). METHODS: This controlled cross-sectional study was based on phone interviews of patients discharged from hospital after COVID-19 compared to the c